Reliabo Pharma India Private Limited
About Reliabo Pharma India Private Limited
Data last updated:
Reliabo Pharma India Private Limited is a private limited company based in Guwahati, Assam, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 26 July 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Guwahati, under CIN U24232AS2012PTC011193. Its GSTIN is 18AAGCR0739J1Z5 (Assam).
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹4.1 Lakh. It is led by directors Manoj Patodia and Prabha Patodia.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Sarat Bhawan S.C. Goswami Road Panbazar, Guwahati, Assam, India – 781001.
As per the financials filed for FY 2024, the company reported a revenue of ₹2.98 Cr, a decline of 56% compared to the previous year. For the same year it recorded a net profit of ₹11.15 Lakh (net margin 3.7%) and EBITDA of ₹20.39 Lakh (EBITDA margin 6.8%). Revenue has declined at a compounded annual rate (CAGR) of 29% over three years and 17% over five years.
Court records list 31 cases involving the company, including 30 filed by the company; 17 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressSarat Bhawan S.C. Goswami Road Panbazar, Guwahati, Assam, India – 781001
- IndustryChemicals, Manufacturing, Other Chemical Product
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Reliabo Pharma India Private Limited
The main business activity of Reliabo Pharma India is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Reliabo Pharma India Private Limited FY 2025 filings available
Reliabo Pharma India Private Limited reported revenue of ₹2.98 Cr (down 56% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Reliabo Pharma India Private Limited
Revenue has declined at a compounded annual rate (CAGR) of 17% over five years, including a 56% fall in the latest year. EBITDA fell 42% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Reliabo Pharma India Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹20.39 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹11.15 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Reliabo Pharma India Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.8% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 3.7% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Reliabo Pharma India are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Reliabo Pharma India Private Limited
Reliabo Pharma India has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manoj Patodia | Director | 26 Jul 2012 | 14 Years 2 Months | Current |
| Prabha Patodia | Director | 15 Mar 2024 | 2 Years 7 Months | Current |
Peer Comparison of Reliabo Pharma India Private Limited
Reliabo Pharma India Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Bio Organic Life Sciences Private Limited | ₹2.99 Cr (FY 2024) | •••• | •••• | 4.0% | •••• | Patna, Bihar, India |
| Delta Plus Lubricants and Chemicals Private Limited | ₹2.99 Cr (FY 2025) | •••• | •••• | 4.0% | •••• | Mumbai, Maharashtra, India |
| Navin Hospicare Private Limited | ₹2.98 Cr (FY 2025) | •••• | •••• | •••• | Noida, Uttar Pradesh, India | |
| Savom Remedies P.Ltd. | ₹2.98 Cr (FY 2025) | •••• | •••• | -6.0% | •••• | Mumbai-4000102, Maharashtra, India |
| Cortina Laboratories Private Limited | ₹2.98 Cr (FY 2025) | •••• | •••• | -5.0% | •••• | Lucknow, Uttar Pradesh, India |
| Reliabo Pharma India Private Limited this company | ₹2.98 Cr (FY 2024) | •••• | •••• | -56.0% | •••• | Guwahati, Assam, India |
| Reda Pharma Private Limited | ₹2.97 Cr (FY 2025) | •••• | •••• | -1.0% | •••• | Hyderabad, Telangana, India |
| Ace Lifecare Private Limited | ₹2.97 Cr (FY 2017) | •••• | •••• | 30.0% | •••• | Ahmedabad, Gujarat, India |
| Drishtee Medicos and Surgicals Private Limited | ₹2.96 Cr (FY 2025) | •••• | •••• | 2.0% | •••• | Dwarka, New Delhi, Delhi, India |
| Daryabadi Agencies Private Limited | ₹2.96 Cr (FY 2025) | •••• | •••• | 2.0% | •••• | Mumbai, Maharashtra, India |
| Rantomo Life Sciences Bharat Private Limited | ₹2.96 Cr (FY 2025) | •••• | •••• | 8593.0% | •••• | Mumbai, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Reliabo Pharma India by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Charges & Borrowings of Reliabo Pharma India Private Limited
Reliabo Pharma India Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Legal Cases of Reliabo Pharma India Private Limited
Reliabo Pharma India Private Limited has 31 court cases on record: 30 filed by Reliabo Pharma India, 1 where it is another party. 17 cases are pending and 14 are disposed. Status as checked between 28 Sep 2026 and 04 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 30 | 0 | 16 |
| High courts | 1 | 0 | 1 |
Cases on record (5 of 31)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Kamrup Metro, Assam | Court case (N I Act) | Filed by the company against an individual | Pending |
| District court, Kamrup Metro, Assam | Court case (N I Act) | Filed by the company against Kunjal Pharmaceuticals | Pending |
| Bombay High Court | Court case (COMIP) | Company is another party | Pending |
| District court, Kamrup Metro, Assam | Court case (N I Act) | Filed by the company against an individual | Pending |
| District court, Kamrup Metro, Assam | Court case (Complaint Case C.R.) | Filed by the company against Sas Pharma | Pending |
Full case history
All 31 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Reliabo Pharma India Private Limited
Employment history and EPFO contributions of people linked to Reliabo Pharma India.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Reliabo Pharma India Private Limited
Reliabo Pharma India Private Limited has 3 board changes on record since 2012: 2 appointments and 1 cessation. The latest: Prabha Patodia was appointed as Director on 15 Mar 2024.
Credit Ratings, Litigation & Regulatory Alerts for Reliabo Pharma India Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Reliabo Pharma India Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Reliabo Pharma India Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Reliabo Pharma India Private Limited
Reliabo Pharma India has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 18AAGCR0739J1Z5 | Assam | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Reliabo Pharma India Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Reliabo Pharma India Private Limited
Reliabo Pharma India is an active private limited company based in Guwahati, Assam, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 26 July 2012 (14+ years old) and is registered under CIN U24232AS2012PTC011193.
Reliabo Pharma India reported revenue of ₹2.98 Cr for FY 2024 (down 56% YoY).
Reliabo Pharma India has 2 current directors:
- Manoj Patodia - Director
- Prabha Patodia - Director
Reliabo Pharma India reported a net profit of ₹11.15 Lakh (net margin 3.7%) and EBITDA of ₹20.39 Lakh (EBITDA margin 6.8%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Reliabo Pharma India is -29% over three years and -17% over five years. In the latest year (FY 2024) revenue fell 56%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Reliabo Pharma India is 18AAGCR0739J1Z5, registered in Assam.
The CIN (Corporate Identification Number) of Reliabo Pharma India is U24232AS2012PTC011193. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Reliabo Pharma India has 31 court cases on record: 30 filed by the company. 17 are pending. Most are in the district courts.
Reliabo Pharma India was incorporated on 26 July 2012, making it 14+ years old. It is registered with the Registrar of Companies, Guwahati.
The peers of Reliabo Pharma India by revenue are Bio Organic Life Sciences Private Limited, Delta Plus Lubricants and Chemicals Private Limited, Navin Hospicare Private Limited, Savom Remedies P.Ltd, Cortina Laboratories Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).
Prabha Patodia was appointed as Director on 15 Mar 2024. Sarwan Jhunjhunwala ceased to be Director on 15 Mar 2024. Manoj Patodia was appointed as Director on 26 Jul 2012.